[PDF] Examining The Increase In Drug Shortages - eBooks Review

Examining The Increase In Drug Shortages


Examining The Increase In Drug Shortages
DOWNLOAD

Download Examining The Increase In Drug Shortages PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Examining The Increase In Drug Shortages book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





Examining The Increase In Drug Shortages


Examining The Increase In Drug Shortages
DOWNLOAD
Author : United States. Congress
language : en
Publisher: Createspace Independent Publishing Platform
Release Date : 2017-09-30

Examining The Increase In Drug Shortages written by United States. Congress and has been published by Createspace Independent Publishing Platform this book supported file pdf, txt, epub, kindle and other format this book has been release on 2017-09-30 with categories.


Examining the increase in drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 23, 2011.



Examining The Increase In Drug Shortages


Examining The Increase In Drug Shortages
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
language : en
Publisher:
Release Date : 2013

Examining The Increase In Drug Shortages written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013 with Drug accessibility categories.




Examining The Increase In Drug Shortages


Examining The Increase In Drug Shortages
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
language : en
Publisher:
Release Date : 2013

Examining The Increase In Drug Shortages written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2013 with Drug accessibility categories.




Examining Drug Shortages And Recent Efforts To Address Them


Examining Drug Shortages And Recent Efforts To Address Them
DOWNLOAD
Author : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
language : en
Publisher:
Release Date : 2014

Examining Drug Shortages And Recent Efforts To Address Them written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014 with Drug accessibility categories.




Prescription Drug Shortages


Prescription Drug Shortages
DOWNLOAD
Author : United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
language : en
Publisher:
Release Date : 2014

Prescription Drug Shortages written by United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014 with Drug accessibility categories.




The Rising Costs Of Hospital Pharmaceutical Shortages And The Impact On Patient Care


The Rising Costs Of Hospital Pharmaceutical Shortages And The Impact On Patient Care
DOWNLOAD
Author : LeTicia Laura Currin
language : en
Publisher:
Release Date : 2020

The Rising Costs Of Hospital Pharmaceutical Shortages And The Impact On Patient Care written by LeTicia Laura Currin and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020 with COVID-19 (Disease) categories.


This qualitative case study examined the rising cost of hospital pharmaceutical shortages and the impact on patient care. This study also explored the use of predictive analytics to reduce costs and improve patient care efficiency. Increased health-care spending is partially due to prescription medication prices. Management of hospital drug procurement affects patient health, quality care, and hospital budgets, while risk management needs to minimize possible medication shortages. For patients to get the drugs that they need, pharmacists need to have resources at their fingertips to obtain a deep insight into the knowledge of drugs through the supply chain. The research questions concentrated on the causes of rising costs, the role of supply and demand, and the possibility of predictive analytics as a tool for inefficiencies relating to rising costs of hospital pharmaceutical shortages. The unexpected factor in this study was the impact of the Coronavirus (COVID-19) pandemic. Not only did COVID-19 alter the data collection method, but the data itself. Hospital pharmaceuticals were and still are greatly affected by the pandemic. The findings from this study was applied to the professional practice of business. Additionally, the researcher discussed the implication of the biblical worldview and the implication of the strategic management field of study. The report finished with suggestions for practice, suggestions for further analysis, reflections, and conclusions. The researcher also recommended that the study be conducted again with a specific pharmaceutical shortage and no global pandemic.



Drug Shortages Pricing And Regulatory Activity


Drug Shortages Pricing And Regulatory Activity
DOWNLOAD
Author : Christopher Stomberg
language : en
Publisher:
Release Date : 2016

Drug Shortages Pricing And Regulatory Activity written by Christopher Stomberg and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016 with Drug accessibility categories.


This study examines the patterns and causes of shortages in generic non-injectable drugs (e.g., tablets and topicals) in the United States. While shortages for injectable drugs have garnered more attention, shortages of other forms of prescription drugs have also been on the increase. In fact, they follow a strikingly similar trend with a number of important tablet drugs having recently been affected by shortage. This poses important questions about the root causes of these trends since most explanations found in the literature are specific to generic injectable drugs. Using a simple heuristic framework, three contributing factors are explored: regulatory oversight, potential market failures in pricing/reimbursement, and competition. This paper features an empirical examination of the contribution of changes in regulatory oversight to drug shortages. A pooled dynamic regression model using FDA data on inspections and citations reveals a statistically significant relationship between FDA regulatory activity (inspections and citations) and drug shortage rates. This result cuts across both injectable and non-injectable drugs, and could reveal a transition in equilibrium quality that should be transitory in nature, but it should also be interpreted with care given the other factors likely affecting shortage rates.



Making Medicines Affordable


Making Medicines Affordable
DOWNLOAD
Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2018-03-01

Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-01 with Medical categories.


Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.



Ending Discrimination Against People With Mental And Substance Use Disorders


Ending Discrimination Against People With Mental And Substance Use Disorders
DOWNLOAD
Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2016-09-03

Ending Discrimination Against People With Mental And Substance Use Disorders written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-09-03 with Social Science categories.


Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.



Managing Supply Chain Risk


Managing Supply Chain Risk
DOWNLOAD
Author : ManMohan S. Sodhi
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-02-25

Managing Supply Chain Risk written by ManMohan S. Sodhi and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-02-25 with Business & Economics categories.


“Supply Chain Risk Management is an issue that many companies face and yet few companies know how to deal with it in a systematic and pragmatic manner. While avoiding and reducing supply chain risks are certainly preferable, developing ways to restore and stabilize supply chain operations rapidly after a major disruption is critical for managing global supply chains. Sodhi and Tang present important concepts, frameworks, strategies, and analyses that are essential for managing supply chain risks. Not only does this book suggest some practical ways to work with different partners to manage the risks that are present in a global supply chain, it creates a framework that would enable practitioners to engage researchers to work on this important area.” —Thomas A. Debrowski, Executive Vice President, Worldwide Operations, Mattel, Inc. “When a firm outsources its operations to external suppliers, the firm is vulnerable to major and rare disruptions that can occur at any link in the global supply chain. Because these disruptions rarely occur, few firms take commensurable actions to identify, assess, mitigate and respond to various types of supply chain risks. By introducing frameworks and concepts along with several case studies and a review of academic literature, Sodhi and Tang treat this important subject with practical relevance and academic rigor. This book will bring practitioners and researchers to develop effective and efficient ways to manage supply chain risks.” —Marshall L. Fisher, UPS Professor, Professor of Operations and Information Management and Co-Director of Fishman-Davidson Center for Service and Operations Management, The Wharton School, University of Pennsylvania “This book ties observations in practice to methodologies and research. The rich case examples motivated the approaches and methodologies used to mitigate risks, and in the course of doing so, Sodhi and Tang provided insights on existing and new research opportunities. As a result, this book is highly relevant to both practitioners and academics. Also, the book is also written with management lessons on how risks can be mitigated, and how risks can be contained once disruptions have occurred. As such, it is also a book for management to gain insights and to develop management skills.” —Hau L. Lee, Thoma Professor of Operations, Information and Technology and Director of the Stanford Global Supply Chain Management Forum, Graduate School of Business, Stanford University “As companies have extended their supply chains globally and as the face increasing resource issues, they face a number of new risk challenges. While there are various case studies written about supply chain risks, this book gives a comprehensive treatment of the subject with clarity. The concepts and frameworks developed by Sodhi and Tang in this book would create awareness of this important and yet not well understood subject, and strategies described in this book would stimulate practitioners to develop a holistic approach for identifying, assessing, mitigating, and responding to different types of supply chain risks.” —Nick Wildgoose, Global Supply Chain Proposition Manager, Zurich Insurance​